AnandRathi

Marksans Pharma Ltd Share Price

Last Updated Date: 22 Oct 2026
₹294.50
-2.95 (-0.99%)

As of 22 Oct 2026, Marksans Pharma Ltd share price is ₹294.50. The stock opened at ₹294.50 and had closed at ₹297.45 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹156.00 and a high of ₹350.75. In terms of performance, Marksans Pharma Ltd share price has increased by 56.35% over the past six months and has increased by 66.87% over the last year.

MARKSANS Stock Price Chart

Marksans Pharma Ltd Overview

Market cap₹13,479 Crs
Volume47,893
Prev. Close₹297.45
Year range₹156.00 - ₹350.75
ISININE750C01026

About MARKSANS

Marksans Pharma engaged in the business of research, manufacture, marketing and selling pharmaceutical formulations. It operates two manufacturing facilities in Goa and maintains two R&D centers; one located in Goa and the other in Navi Mumbai, Maharashtra.

Marksans Pharma Ltd Historical Performance

1 Month Return-12.04%
6 Month Return68.15%
3 Year Return178.51%
3 Month Return14.25%
1 Year Return65.16%
5 Year Return350.34%

Marksans Pharma Ltd Fundamentals

ROCE(TTM)23.60%
P/E Ratio (TTM)41.89
P/B Ratio8.16
Debt to Equity0.01
ROE18.20%
EPS (TTM)7.10
Dividend Yield0.30%
Book Value36.46
Profit Margin23.95%
Operating Margin22.40%

Marksans Pharma Ltd Financials

IndicatorMar 26Mar 25Mar 24Mar 23Mar 22
Revenue1,445.011,240.16915.34715.68700.54
EBITDA427.10273.88202.01152.39155.97
Net Profit300.70188.27133.76102.87103.99
EPS6.644.152.952.482.54

Marksans Pharma Ltd Technical Analysis

IndicatorValue
Support 1 (S1)291.62
Resistance 1 (R1)305.12
Pivot Point299.28

Marksans Pharma Ltd Dividend History

Ex DateDividends DateRecord DateDividend TypeDividend Details
20-Aug-202626-May-202620-Aug-2026Final₹0.90
01-Aug-202519-May-202501-Aug-2025Final₹0.80
17-Sep-202430-May-202417-Sep-2024Final₹0.60
07-Jun-202330-May-202307-Jun-2023Final₹0.50
19-Aug-202230-May-202223-Aug-2022Final₹0.25

MARKSANS Latest Shareholding

  • Promoters Holding (43.87%)
  • FIIs Holding (15.33%)
  • DIIs Holding (5.54%)
  • Public Holding (27.05%)
  • Mutual Fund (3.72%)
  • Others (4.48%)

MARKSANS Key Leadership Details

Last Updated: Mar 2026

NamePosition
Mark SaldanhaCMD & Executive Directorector
Sandra SaldanhaWhole Time Executive Directorector
Varddhman Vikramaditya JainIndependent Director

Marksans Pharma Ltd Peer Comparison

CompanyPriceM.Cap (Cr)P/E (TTM)ROE (TTM)
Sun Pharmaceutical Industries LtdSUNPHARMA
₹1,749.10+0.23%
₹4,19,727.6638.3213.74%
Divis Laboratories LtdDIVISLAB
₹9,115.50-0.81%
₹1,67,235.9167.4615.32%
Torrent Pharmaceuticals LtdTORNTPHARM
₹4,597.90+0.97%
₹1,46,951.3264.6825.49%

Disclaimer

The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...

Frequently Asked Questions

Download TradeMobi App

  • Real-Time Market Data
  • Advanced Trading Tools
  • Expert-Backed Research